FDA Authorizes Bivalent Pfizer Booster for Babies

‘Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to provide for a single booster dose of the vaccine in children 6 months through 4 years of age at least 2 months after completion of primary vaccination with three doses of the monovalent (single strain) Pfizer-BioNTech COVID-19 Vaccine.’
www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-bivalent-pfizer-biontech-covid-19-vaccine-booster-dose

We are primarily funded by readers. Please subscribe and donate to support us!

h/t A Deplorable Neanderthal

Views:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.